QEZ-33186-79332
3 vaccinations
6 coded responses
34 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 062 / CT
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Registered in v-safe
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-09
Survey response — day 0, dose 1MedDRA: Dysgeusia, Immediate post-injection reaction — Feeling: Fair · Site: Pain, Itching · Fever · Headache, Muscle or body achesFree text: Metallic taste in mouth immediatelyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-10
- 2021-04-11
- 2021-04-13
- 2021-04-14
- 2021-04-15
-
2021-05-01
Dose 2 — Pfizer-BioNTech
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint painsAdult check-in
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-08
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-06-05
-
2021-06-12
Survey response — day 42, dose 2MedDRA: Nasopharyngitis — Feeling: FairFree text: ColdMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-31
-
2021-11-01
Survey response — 6 months, dose 2MedDRA: Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue and headachesMedDRA releases: 2024-11 · check-in free text available
-
2021-12-17
Dose 3 — Pfizer-BioNTech
-
2021-12-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, NauseaAdult check-in
-
2021-12-19
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Abdominal painAdult check-in
- 2021-12-20
- 2021-12-21
- 2021-12-22
- 2021-12-23
- 2021-12-24
-
2021-12-31
Survey response — day 14, dose 3MedDRA: Dizziness — Feeling: Fair · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
- 2022-01-07
- 2022-01-14
- 2022-01-22
- 2022-01-28
- 2022-03-19
-
2022-06-17
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: FairFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-12-18
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: CovidMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-05-01 | Pfizer-BioNTech | |
| 3 | 2021-12-17 | Pfizer-BioNTech | No |
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): Metallic taste in mouth immediately
Release 9 — day 42, dose 2
Symptoms: Cold
Release 10 — 6 months, dose 2
Symptoms: Fatigue and headaches
Release 10 — day 14, dose 3
Symptoms: Dizziness
Release 12 — 6 months, dose 3
Symptoms: Pregnancy
Release 12 — 12 months, dose 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release